FDA
approval
· 2025-04-29
FDA Approved: RELEUKO — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved a supplemental application for RELEUKO (filgrastim) from Amneal Pharmaceuticals LLC. This reflects regulatory action on a supplemental submission f…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RELEUKO (FILGRASTIM)